Suggestions
Simon Bachmann
CEO at IDUN Technologies
Simon Bachmann is the co-founder and CEO of IDUN Technologies AG, a Swiss neurotech startup focused on revolutionizing brain-sensing technology.16 He graduated from ETH Zurich with a Master's degree in Health Science & Technology, specializing in Medical Technology.14
Bachmann co-founded IDUN Technologies in 2017 as a spin-off from ETH Zurich, along with Séverine Gisin.2 The company develops soft, conductive biopotential electrodes, with a particular focus on in-ear EEG technology for measuring brain activity.12
Under Bachmann's leadership, IDUN Technologies aims to create an empathic digital world by making brain-related information accessible through a platform consisting of hardware designs, data collection, and personalized insights.2 The company has pivoted towards developing EEG-enabled earbuds as a scalable health platform for consumer well-being and health applications.2
Bachmann has been actively representing IDUN Technologies at various events, including the DeepTech Investor Summit 2025.3 He is passionate about the neurotech industry and its potential to improve people's lives through innovative brain-sensing technologies.56
Highlights
🚀 Exciting Insights from Deloitte's Neuroscience Market Analysis! 🧠
Deloitte's recent report sheds light on the growing potential of the global neuroscience market, estimated to reach $721 billion by 2026. Several key trends align perfectly with our vision at #IDUNTechnologies:
🩺 Non-Molecular Diagnostics: A Game-Changer
Non-molecular diagnostics present a unique opportunity for us to generate more relevant real-world data. By leveraging technologies like EEG and integrating them into VR/AR, mobile gaming, and other platforms, we can make diagnostics more longitudinal and comprehensive. This approach not only enhances the accuracy of diagnoses but also facilitates continuous monitoring and personalized care.
💊 The Rise of Non-Drug Therapies
Developing new drugs has become prohibitively expensive, driving the growth of non-drug therapies. Digital therapeutics offer a chance to digitalize drug portfolios, personalize treatment, and boost patient compliance (what can we do for the patient?). Cognitive behavioral therapy, combined with digital therapeutics, can be significantly enhanced through continuous EEG integration, creating immersive and effective treatment experiences. A pioneer in this space is Click Therapeutics, Inc.
🌐 Opportunities Beyond Clinics
The unsustainable cost of drug development underscores the need for innovative mental and brain health solutions outside traditional clinical settings. By combining human sensing with AI, we can build a new generation of preventative, personalized, and immersive applications. These technologies will not only help rehabilitate and maintain health but also push the boundaries to achieve superhuman wellness.
At IDUN Technologies, we want to create access to mental and brain health for everyone.
Thanks Álvaro Nuño Pérez and Sherlee AROKIADASS for this amazing research.
#Neuroscience #DigitalHealth #NonMolecularDiagnostics #DigitalTherapeutics #MentalHealth #Innovation #AI #VR #AR #HealthcareInnovation #IDUNTechnologies
https://lnkd.in/eS2Y7m7G
Dear BCI network, I am looking for people working in the gaming industry, specifically game development and play testing for interviews around using EEG sensing for enhanced gaming experiences, making extended realities more accessible and inclusive and much more. BCI controlled games are one avenue, but I am also interested in adaptive game engines based on passive biometric input and closed-loop applications for rehabilitative purposes.
Please tag your friends and connections and I am happy to chat! Thank you and have a wonderful weekend.
#neurogaming #BCI #neuralinterfaces #BCI4games
Mike Ambinder, PhD Kevin Ellersiek Nico Perony Avery Bedows Eli Kinney-Lang Jeff Brown
